Iovance Biotherapeutics, Inc. ( IOVA ) Shareholders

Iovance Biotherapeutics, Inc. ( IOVA ) Engaged in Illegal Stock Promotion Scheme According to SEC

Iovance Biotherapeutics, Inc. ( IOVA ) (formerly known as Lion Biotechnologies, Inc.)  violated federal securities laws by failing to disclose that the articles and e-mails they disseminated touting the company and promising future prospects to the investing public were actually paid promotions.  This scheme artificially inflated the value of the company’s stock and enriched the company’s CEO, whose compensation was linked to milestones dependent upon Iovance’s stock price increasing.  As a result, the Securities and Exchange commission imposed a $100,000 fine and Iovance is the subject of a securities class action lawsuit.

Do you own shares of Iovance Biotherapeutics, Inc. ( IOVA )?

For more information about your rights and potential remedies, please contact us via the contact form or email Lauren Levi, at

This field is for validation purposes and should be left unchanged.

Having information at your fingertips is easier than ever. Enroll in Robbins LLP’s free investment monitoring service, Stock Watch, for notifications of corporate misconduct impacting the value of your investments, advice on how to hold corporate officers and directors accountable for their misconduct, and to receive information about class action settlements. 

Protect your investments.

Sign up for free investment monitoring.

Stock Watch members receive free investment monitoring and notifications.  

Leave your details to get started